Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.64 USD | -0.82% | -13.54% | +12.35% |
Financials (USD)
Sales 2024 * | 833K | Sales 2025 * | 4.6M | Capitalization | 286M |
---|---|---|---|---|---|
Net income 2024 * | -127M | Net income 2025 * | -136M | EV / Sales 2024 * | 269 x |
Net cash position 2024 * | 61.98M | Net cash position 2025 * | 61.76M | EV / Sales 2025 * | 48.7 x |
P/E ratio 2024 * |
-2.32
x | P/E ratio 2025 * |
-2.32
x | Employees | 140 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.29% |
Latest transcript on Tenaya Therapeutics, Inc.
1 day | -0.82% | ||
1 week | -13.54% | ||
Current month | -13.54% | ||
1 month | -18.75% | ||
3 months | -43.12% | ||
6 months | +82.91% | ||
Current year | +12.35% |
Managers | Title | Age | Since |
---|---|---|---|
Faraz Ali
CEO | Chief Executive Officer | 51 | 18-05-31 |
Leone Patterson
DFI | Director of Finance/CFO | 61 | 21-05-31 |
Kee-Hong Kim
CTO | Chief Tech/Sci/R&D Officer | - | 18-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Williams
BRD | Director/Board Member | 75 | 16-09-30 |
David Goeddel
CHM | Chairman | 72 | 16-07-31 |
Jeffrey Walsh
BRD | Director/Board Member | 58 | 20-02-29 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 32 M€ | +4.30% | - | |
0.00% | 18 M€ | +3.81% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 3.64 | -0.82% | 222,857 |
24-06-06 | 3.67 | -0.27% | 217,259 |
24-06-05 | 3.68 | 0.00% | 441,575 |
24-06-04 | 3.68 | -7.54% | 288,361 |
24-06-03 | 3.98 | -5.46% | 142,057 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.35% | 286M | |
+51.85% | 57.87B | |
+41.65% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- TNYA Stock